Stage FocusSeed, Series A, Series B+
GeographyEurope
TypeCVC
Last Activity2026
Industry Focus
Industries
BiotechMedTech
Technical BenchStrong
Investor TypeCVC
ExposureMostly DeepTech Investments
Bio
Servier Ventures launched in January 2026 as the first CVC initiative for Servier, France's largest private pharmaceutical company. The commitment is €200M (roughly $234M) to the European biotech sector, focused on oncology and neurology therapeutics aligned with Servier's core therapeutic areas.
The fund takes minority stakes in innovative biotech and technology companies, with an initial Europe...
Similar Funds
Novartis Venture Fund
Basel, Switzerland
GeneralistBiotechMedTechSeedSeries A
Pfizer Ventures
New York, United States
GeneralistBiotechMedTechSeedSeries A
Roche Venture Fund
Basel, Switzerland
GeneralistBiotechMedTechSeedSeries A
Sanofi Ventures
Paris, France
GeneralistBiotechMedTechSeedSeries A
Abingworth
London, United Kingdom
DeepTech NativeBiotechMedTechSeedSeries A
BGF
London, United Kingdom
GeneralistBiotechClimate TechAdvanced MaterialsSeedSeries A